Ginkgo Bioworks Holdings, Inc. (DNA)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Ginkgo Bioworks Holdings, Inc. (DNA)
Company Performance

Current Price

as of Dec 02, 2024

$9.61

P/E Ratio

N/A

Market Cap

$552.37M

Description

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. It operates through the Cell Programming/Foundry, and Biosecurity segments. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Metrics

Overview

  • HQBoston, MA
  • SectorHealth Services
  • IndustryMedical/Nursing Services
  • TickerDNA
  • Price$9.61+10.46%

Trading Information

  • Market cap$552.37M
  • Float66.66%
  • Average Daily Volume (1m)1,336,195
  • Average Daily Volume (3m)1,278,790
  • EPS-$12.90

Company

  • Revenue$217.95M
  • Rev growth (1yr)60.65%
  • Net income-$56.40M
  • Gross margin67.24%
  • EBITDA margin-38.71%
  • EBITDA-$34.47M
  • EV$252.33M
  • EV/Revenue1.16
  • P/EN/A
  • P/S2.30
  • P/B0.60
Documents
Factset Street Account